INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 128 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greenwich Wealth Management LLC | 35,300 | $14 | 0.00% |
| Verition Fund Management LLC | 300,045 | $116,718 | 0.00% |
| Prime Capital Investment Advisors, LLC | 138,972 | $54,060 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 460,200 | $178 | 0.00% |
| PDS Planning, Inc | 10,000 | $3,890 | 0.00% |
| TUDOR INVESTMENT CORP ET AL | 226,021 | $87,922 | 0.00% |
| MEANS INVESTMENT CO., INC. | 10,013 | $3,895 | 0.00% |
| American Trust | 23,333 | $9,077 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 829,238 | $322,574 | 0.00% |
| China Universal Asset Management Co., Ltd. | 6,885 | $3 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 4,578,455 | $1,781,019 | 0.00% |
| JANE STREET GROUP, LLC | 268,650 | $104,504 | 0.00% |
| Blume Capital Management, Inc. | 1,000 | $389 | 0.00% |
| ALBION FINANCIAL GROUP /UT | 63 | $25 | 0.00% |
| ATWOOD & PALMER INC | 225 | $88 | 0.00% |
| Pine Valley Investments Ltd Liability Co | 13,250 | $5,155 | 0.00% |
| VICTORY CAPITAL MANAGEMENT INC | 28,871 | $11,231 | 0.00% |
| JPMORGAN CHASE & CO | 62,165 | $24,182 | 0.00% |
| VANGUARD GROUP INC | 20,074,832 | $7,809,110 | 0.00% |
| Allworth Financial LP | 375 | $146 | 0.00% |
External links
This page lists INOVIO PHARMACEUTICALS INC's shareholders in Q3 2023. To view INOVIO PHARMACEUTICALS INC's shareholder history, click here.